Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Proscaline

From Wikipedia, the free encyclopedia
Pharmaceutical compound
Proscaline
Clinical data
Other names4-Propoxy-3,5-dimethoxyphenethylamine; 4-Propoxy-3,5-DMPEA
Routes of
administration
Oral[1]
Drug classSerotonin5-HT2 receptoragonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action8–12 hours[1]
Identifiers
  • 2-(3,5-dimethoxy-4-propoxyphenyl)ethan-1-amine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC13H21NO3
Molar mass239.315 g·mol−1
3D model (JSmol)
  • COc1cc(cc(OC)c1OCCC)CCN
  • InChI=1S/C13H21NO3/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h8-9H,4-7,14H2,1-3H3 checkY
  • Key:HYWLMSUAZVDUFW-UHFFFAOYSA-N checkY
  (verify)

Proscaline, also known as4-propoxy-3,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine andscaline families related tomescaline.[1] It is takenorally.[1][2]

Use and effects

[edit]

In his bookPiHKAL (Phenethylamines I Have Known and Loved) and other publications,Alexander Shulgin reports that a dose of 30 to 60 mgorally produces effects lasting 8 to 12 hours.[1][3][4][2] Theonset was not described, but peak effects occurred after about 2 hours.[1] A typical dose estimate is 45 mg.[2] Doses as high as 80 mg have also been explored.[1] The drug has approximately 6 or 7 times thepotency of mescaline, which itself has a listed dose range of 200 to 400 mg.[1][3][4][5][6]

The effects of proscaline have been reported to include insignificantclosed-eye visuals, sharpening of thesenses,hyperawareness,relaxation and feeling at ease, deep feelings of peace and contentment,euphoria, no enhanced clarity or deep realizations, feelings of uninhibitederoticism,pain relief,drowsiness,intoxication andfeeling drunk,irritability,restlessness,tremors,insomnia, difficulty withdreams, long-lasting residual effects, and no next-dayhangover.[1]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

Proscaline is aserotonin5-HT2 receptoragonist, including of the serotonin5-HT2A,5-HT2B, and5-HT2C receptors.[7][8] Activation of the serotonin 5-HT2A receptor is thought to be responsible for itspsychedelic effects.[7] The drug is much morepotent as an agonist of the serotonin 5-HT2C receptor than as an agonist of the serotonin 5-HT2A or 5-HT2B receptors.[7]

It produces thehead-twitch response, a behavioral proxy of psychedelic effects, in rodents.[7][9][2]

Chemistry

[edit]

Proscaline, also known as 4-propoxy-3,5-dimethoxyphenethylamine, is asubstituted phenethylamine andscaline (4-substituted 3,5-dimethoxyphenethylamine)derivative related tomescaline (3,4,5-trimethoxyphenethylamine).[1] It is the 4-propoxyhomologue of mescaline.[1]

Properties

[edit]

Proscaline is much morelipophilic thanmescaline orescaline (log P = 1.70, 0.78, and 1.11, respectively), which is expected to be more optimal and advantageous in terms ofdrug-like properties such asblood–brain barrierpermeability.[9]

Synthesis

[edit]

Thechemical synthesis of proscaline has been described.[1]

Analogues

[edit]

Analogues of proscaline includemescaline,escaline,isoproscaline,allylescaline,methallylescaline,cyclopropylmescaline,cycloproscaline,fluoroproscaline, and3C-P, among others.[1][10][11]

History

[edit]

Proscaline was firstsynthesized and studied by Otakar Leminger in 1972.[12][1] The drug was later synthesized byAlexander Shulgin and further described in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1] It was encountered as a noveldesigner drug inEurope in 2013.[13][14][9]

Society and culture

[edit]

Legal status

[edit]

United Kingdom

[edit]

Proscaline is aClass A controlled substance in theUnited Kingdom.[citation needed]

United States

[edit]

Proscaline is not directly scheduled under theControlled Substances Act in theUnited States. However, due to its structural similarities with mescaline, a Schedule I drug, it could potentially be subject to the same control measures and penalties for possession and manufacture under the Federal Analogue Act.[citation needed]

See also

[edit]

References

[edit]
  1. ^abcdefghijklmnoProscaline entry in PiHKAL
  2. ^abcdHalberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (May 2020)."Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species"(PDF).Neuropharmacology.167 107933.doi:10.1016/j.neuropharm.2019.107933.PMC 9191653.PMID 31917152.Table 4 Human potency data for selected hallucinogens. [...]
  3. ^abJacob P, Shulgin AT (1994)."Structure-activity relationships of the classic hallucinogens and their analogs".NIDA Res Monogr.146:74–91.PMID 8742795.
  4. ^abShulgin AT (2003)."Basic Pharmacology and Effects". In Laing RR (ed.).Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137.ISBN 978-0-12-433951-4.
  5. ^Alexander T. Shulgin (1980)."Hallucinogens". In Burger A, Wolf ME (eds.).Burger's Medicinal Chemistry. Vol. 3 (4 ed.). New York: Wiley. pp. 1109–1137.ISBN 978-0-471-01572-7.OCLC 219960627.
  6. ^Shulgin AT (1982)."Chemistry of Psychotomimetics". In Hoffmeister F, Stille G (eds.).Psychotropic Agents, Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs. Handbook of Experimental Pharmacology. Vol. 55 / 3. Berlin: Springer Berlin Heidelberg. pp. 3–29.doi:10.1007/978-3-642-67770-0_1.ISBN 978-3-642-67772-4.OCLC 8130916.
  7. ^abcdWallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, Hennessey JJ, Bock HA, Anderson EI, Sherwood AM, Morris H, de Klein R, Klein AK, Cuccurazzu B, Gamrat J, Fannana T, Zauhar R, Halberstadt AL, McCorvy JD (December 2023)."Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential".Nat Commun.14 (1) 8221.Bibcode:2023NatCo..14.8221W.doi:10.1038/s41467-023-44016-1.PMC 10724237.PMID 38102107.
  8. ^McCorvy JD (16 January 2013).Mapping the binding site of the 5-HT2A receptor using mutagenesis and ligand libraries: Insights into the molecular actions of psychedelics (Ph.D. thesis). Purdue University. Archived from the original on 15 May 2025. Retrieved27 May 2025 – via Purdue e-Pubs.{{cite thesis}}: CS1 maint: bot: original URL status unknown (link)
  9. ^abcHalberstadt AL, Chatha M, Chapman SJ, Brandt SD (March 2019)."Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice".J Psychopharmacol.33 (3):406–414.doi:10.1177/0269881119826610.PMC 6848748.PMID 30789291.
  10. ^Trachsel D (2012). "Fluorine in psychedelic phenethylamines".Drug Test Anal.4 (7–8):577–590.doi:10.1002/dta.413.PMID 22374819.
  11. ^Kolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME (2021)."Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines".Front Pharmacol.12 794254.doi:10.3389/fphar.2021.794254.PMC 8865417.PMID 35222010.
  12. ^Leminger, Otakar (1972)."The Chemistry of Alkoxylated Phenethylamines – Part 2".Chemický Průmysl.22: 553.
  13. ^King LA (2014). "New phenethylamines in Europe".Drug Test Anal.6 (7–8):808–818.doi:10.1002/dta.1570.PMID 24574327.
  14. ^https://isomerdesign.com/bitnest/external/EMCDDA/New-Drugs-In-Europe-2013

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=Proscaline&oldid=1323693498"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp